STAT+: ‘Quite puzzling’ results in Alzheimer’s study cloud future of tau-targeting antibody treatment

New clinical trial results may temper early hope for an experimental Genentech treatment that targets “tangles” of a protein called tau that’s thought to damage and kill neurons.

Click to view original post